Solana Company (HSDT) - News Archive

In a strategic pivot that underscores its commitment to harnessing the power of decentralized finance, Solana Company (NASDAQ: HSDT) has announced its latest moves to enhance its treasury management by partnering with l...

Breaking Ground in Neurorehabilitation: Helius Medical s PoNS Device Gains Momentum with New Reimbursements and Clinical Trials Newtown, Pa. April 24, 2024 Helius Medical Technologies, Inc. (Nasdaq:HSDT), a pioneering n...

In today’s ever-evolving healthcare landscape, breakthrough technologies are often met with regulatory hurdles that inhibit their market potential. Helius Medical Technologies, Inc. (NASDAQ: HSDT), a pioneering force in...

Helius Medical Technologies Announces Key Updates on CMS Reimbursement and Clinical Programs for PoNS Device Helius Medical Technologies, Inc. a neurotech company focused on developing non-implantable and wearable devic...

Unlocking New Horizons for MS Gait Improvement: Positive Results from Helius Medical Technologies PoNSTEP StudyIn an exciting development for the field of neurological rehabilitation, Helius Medical Technologies, Inc. h...

Helius Medical Technologies, Inc. Announces Inducement Grants and Reports Negative Return on InvestmentNEWTON, Pa., Aug. 16, 2024 - Helius Medical Technologies, Inc. (Nasdaq: HSDT), a leading neurotech company focused o...

Helius Medical Technologies Inc (NASDAQ: HSDT) is a rising star in the healthcare industry, specializing in innovative medical technologies focused on neurological wellness. With a strong leadership team, recent signs o...

As global markets grapple with uncertainties, recent developments in China s economy and the performance of Helius Medical Technologies Inc. have caught the attention of investors. CSIMarket.com delves into these contra...

IntroductionHelius Medical Technologies, Inc. has reached a significant milestone in its U.S. Registrational Program in Stroke, announcing the completion of site participation enrollment. This groundbreaking program aim...

Approval Provides U.S. Veterans and Other U.S. Government Agency Employees Access to the Only Portable Neurostimulation Therapy with the Potential to Generate NeuroplasticityNEWTOWN, Pa., May 20, 2024 - Helius Medical T...

Following their previous announcement, Helius Medical Technologies, Inc. (NASDAQ: HSDT), a leading neurotech firm specializing in the delivery of novel therapeutic neuromodulation programs for balance and gait irregular...

Helius Medical Technologies, Inc. is experiencing significant developments in its quest to revolutionize therapeutic neuromodulation for balance and gait deficits. The company recently announced the successful pricing o...

Helius Medical Technologies, Inc., a pioneer in novel therapeutic neuromodulation approaches, has announced its alliance with Shepherd Center for expanding its stroke clinical program focused on restoring walking mobili...

Expanding Access to Innovative Neuromodulation Therapy for Multiple Sclerosis PatientsIn a groundbreaking partnership, Helius Medical Technologies, Inc. has joined forces with Lovell Government Services to extend the re...

Neuromodulation Therapy Holds Promise for Stroke Rehabilitation: Open-Label Study Evaluating Portable Neuromodulation Stimulator Shows Encouraging Results in Improving Gait and BalanceStroke is a leading cause of long-t...

Helius Medical Technologies Secures Reimbursement Milestone for Revolutionary MS Treatment Device, Extends Financial Stability Until 2024In a significant development for the healthcare industry, Helius Medical Technolog...

Helius Medical Technologies, Inc. Expands Stroke Program and Sees Significant Revenue IncreaseIn an exciting development, Helius Medical Technologies, Inc. has announced the expansion of its stroke clinical program with...

Helius Medical Technologies, Inc. Receives Letter of Intent from Québec Ministry of Health and Social Services to Purchase 30 PoNS DevicesHelius Medical Technologies, Inc., a leading neurotech company specializing in th...